Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-100
Closed -$17K – 9126
2015
Q2
$17K Hold
100
– – ﹤0.01% 7063
2015
Q1
$17K Buy
+100
New +$17.1K ﹤0.01% 7189
2014
Q4
– Sell
-100
Closed -$14K – 11092
2014
Q3
$14K Sell
100
-500
-83% -$73.8K ﹤0.01% 8502
2014
Q2
$86K Buy
600
+500
+500% +$71.4K ﹤0.01% 6131
2014
Q1
$15K Sell
100
-3,700
-97% -$512K ﹤0.01% 8497
2013
Q4
$509K Sell
3,800
-100
-3% -$13.2K ﹤0.01% 4318
2013
Q3
$449K Buy
3,900
+3,700
+1,850% +$424K ﹤0.01% 4254
2013
Q2
$22K Hold
200
– – ﹤0.01% 7810

Other funds holding BCR

UBS Group's BCR Position: Q4 2017 in Review

UBS Group sold out of CR Bard (BCR) in Q4 2017, closing a stake of 187,128 shares — an estimated $60M sold.

UBS Group first reported a position in BCR in Q2 2013 and held it in 18 quarters. The position peaked at $60M in Q3 2017. 112 funds tracked by Wall St. Rank hold BCR as of Q4 2017.

  • UBS Group reported no remaining CR Bard position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 187,128 CR Bard shares in Q4 2017, an estimated $60M.
  • UBS Group first reported a position in CR Bard in Q2 2013 and held it in 18 quarters.
  • UBS Group's CR Bard position peaked at $60M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held CR Bard as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.